Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban versus enoxaparin for radial artery thrombosis after coronary angiography
IRCT20200111046084N1Phase 2Completed
- Sponsor
- Rajaie Cardiovascular Medical and Research Center
- Start
- Sep 2018
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in Radial artery thrombosis (RAT) comparing Rivaroxaban with Enoxaparin (2 arms). Primary endpoints: Radial artery recanalization and Bleeding. Started Sep 2018; status: completed.
02
Drugs
rivaroxabanenoxaparin
03
Conditions
Radial artery thrombosis (RAT)
Beyond the preview
Go deeper on IRCT20200111046084N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200111046084N1.